TKT and hepatocellular carcinoma: Overexpression of TKT in tumor types with faster proliferation rates (e.g., pancreatic and HCC) is usually associated with a poor prognosis, because TKT supports tumor cell growth and survival by enhancing the activity of the PPP, promoting nucleotide synthesis and enhancing cellular antioxidant capacity.